Manulife (Manufacturers Life Insurance)
DICE

Manulife (Manufacturers Life Insurance)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,222
Closed -$707K – 3042
2023
Q2 		$707K Sell
15,222
-45,987
-75% -$1.59M ﹤0.01% 1840
2023
Q1 		$1.75M Buy
61,209
+5,900
+11% +$175K ﹤0.01% 1434
2022
Q4 		$1.72M Buy
55,309
+2,298
+4% +$74.9K ﹤0.01% 1427
2022
Q3 		$1.05M Sell
53,011
-284
-0.5% -$5.17K ﹤0.01% 1584
2022
Q2 		$817K Buy
53,295
+5,707
+12% +$98.2K ﹤0.01% 1741
2022
Q1 		$917K Buy
+47,588
New +$849K ﹤0.01% 1797

Manulife (Manufacturers Life Insurance)'s DICE Position: Q3 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 15,222 shares — an estimated $707K sold.

Manulife (Manufacturers Life Insurance) first reported a position in DICE in Q1 2022 and held it in 6 quarters. The position peaked at $1.75M in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 15,222 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $707K.
  • Manulife (Manufacturers Life Insurance) first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s DICE Therapeutics, Inc. Common Stock position peaked at $1.75M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2023, filed 15 Nov 2023.